Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial.
Ouchi Y, Sasaki J, Arai H, Yokote K, Harada K, Katayama Y, Urabe T, Uchida Y, Hayashi M, Yokota N, Nishida H, Otonari T, Arai T, Sakuma I, Sakabe K, Yamamoto M, Kobayashi T, Oikawa S, Yamashita S, Rakugi H, Imai T, Tanaka S, Ohashi Y, Kuwabara M, Ito H. Ouchi Y, et al. Among authors: sakuma i. Circulation. 2019 Sep 17;140(12):992-1003. doi: 10.1161/CIRCULATIONAHA.118.039415. Epub 2019 Aug 22. Circulation. 2019. PMID: 31434507 Clinical Trial.
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, Ogawa T, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Yamazaki T, Ito H, Otsuji Y, Kimura K, Takahashi J, Hirayama A, Yokoi H, Kitagawa K, Urabe T, Okada Y, Terayama Y, Toyoda K, Nagao T, Matsumoto M, Ohashi Y, Kaneko T, Fujita R, Ohtsu H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Inoue T, Matsuzaki M, Nagai R. Taguchi I, et al. Among authors: sakuma i. Circulation. 2018 May 8;137(19):1997-2009. doi: 10.1161/CIRCULATIONAHA.117.032615. Circulation. 2018. PMID: 29735587 Free PMC article. Clinical Trial.
Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individuals.
Hayashi T, Kubota K, Kawashima S, Sone H, Watanabe H, Ohrui T, Yokote K, Takemoto M, Araki A, Noda M, Noto H, Sakuma I, Yoshizumi M, Ina K, Nomura H; Japan CDM group. Hayashi T, et al. Among authors: sakuma i. Int J Cardiol. 2014 Dec 20;177(3):860-6. doi: 10.1016/j.ijcard.2014.10.093. Epub 2014 Nov 5. Int J Cardiol. 2014. PMID: 25466567
Rationale and Design of Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease (REAL-CAD) Trial.
Miyauchi K, Kimura T, Shimokawa H, Daida H, Iimuro S, Iwata H, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Ohashi Y, Ohtsu H, Saito Y, Matsuzaki M, Nagai R; REAL-CAD Trial Investigaters. Miyauchi K, et al. Among authors: sakuma i. Int Heart J. 2018 Mar 30;59(2):315-320. doi: 10.1536/ihj.17-557. Epub 2018 Mar 5. Int Heart J. 2018. PMID: 29503404 Free article. Clinical Trial.
Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan　- Insights From GARFIELD-AF.
Koretsune Y, Etoh T, Katsuda Y, Suetsugu T, Kumeda K, Sakuma I, Eshima K, Shibuya M, Ando SI, Yokota N, Goto S, Pieper KS, Allu J, Kakkar AK; GARFIELD-AF Investigators. Koretsune Y, et al. Among authors: sakuma i. Circ J. 2018 Dec 25;83(1):67-74. doi: 10.1253/circj.CJ-18-0655. Epub 2018 Dec 4. Circ J. 2018. PMID: 30518731 Free article. Clinical Trial.
Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease　- An Observation From the REAL-CAD Study.
Toyota T, Morimoto T, Iimuro S, Fujita R, Iwata H, Miyauchi K, Inoue T, Nakagawa Y, Nishihata Y, Daida H, Ozaki Y, Suwa S, Sakuma I, Furukawa Y, Shiomi H, Watanabe H, Yamaji K, Saito N, Natsuaki M, Ohashi Y, Matsuzaki M, Nagai R, Kimura T. Toyota T, et al. Among authors: sakuma i. Circ J. 2023 Jan 25;87(2):360-367. doi: 10.1253/circj.CJ-22-0168. Epub 2022 Sep 14. Circ J. 2023. PMID: 36104250 Free article.
Thrombotic Risk Stratification and Intensive Statin Therapy for Secondary Prevention of Coronary Artery Disease　- Insights From the REAL-CAD Study.
Natsuaki M, Morimoto T, Iimuro S, Fujita R, Iwata H, Miyauchi K, Inoue T, Nakagawa Y, Nishihata Y, Daida H, Ozaki Y, Suwa S, Sakuma I, Furukawa Y, Shiomi H, Watanabe H, Yamaji K, Saito N, Matsuzaki M, Nagai R, Kimura T; REAL-CAD Investigators. Natsuaki M, et al. Among authors: sakuma i. Circ J. 2022 Aug 25;86(9):1416-1427. doi: 10.1253/circj.CJ-22-0315. Epub 2022 Aug 5. Circ J. 2022. PMID: 35934778 Free article. Clinical Trial.
Comorbidities Associated With Residual Cardiovascular Risk in Patients With Chronic Coronary Syndrome Receiving Statin Therapy　- Subanalysis of the REAL-CAD Trial.
Wakabayashi K, Suzuki H, Fukumoto Y, Obara H, Kakuma T, Sakuma I, Kimura T, Iimuro S, Daida H, Shimokawa H, Nagai R. Wakabayashi K, et al. Among authors: sakuma i. Circ Rep. 2022 Aug 24;4(9):422-428. doi: 10.1253/circrep.CR-22-0070. eCollection 2022 Sep 9. Circ Rep. 2022. PMID: 36120482 Free PMC article.
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.
Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Nohara R, et al. Among authors: sakuma i. Circ J. 2012;76(1):221-9. doi: 10.1253/circj.cj-11-0887. Epub 2011 Nov 16. Circ J. 2012. PMID: 22094911 Free article. Clinical Trial.
491 results